Medical device maker Boston Scientific on Wednesday lowered its annual profit forecast, citing pressure on its Watchman heart device business.
Boston Scientific Corp (BSX) released its 8-K filing on July 29, 2026, highlighting a solid quarter with net sales of $5.442 billion, a 7.5% increase compared t
MARLBOROUGH, Mass., July 29, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.442 billion during the second quarter of 2026, growing 7.5 percent on a reported b
Wall Street analysts are busy reshuffling their ratings ahead of the Fed meeting, with surprise double-upgrades, dramatic target cuts, and fresh initiations spanning surgical robots to cybersecurity.
Boston Scientific's board has approved a new company-wide restructuring plan aimed at cutting costs ​and to better position the company ‌for future growth, the medical device maker said in a regul
Delta Global Management LP acquired a new position in Boston Scientific Corporation (NYSE: BSX) during the first quarter, according to its most recent 13F filing with the SEC. The firm acquired 28,012
Besides Wall Street's top-and-bottom-line estimates for Boston Scientific (BSX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared durin
Bank of Nova Scotia raised its holdings in shares of Boston Scientific Corporation (NYSE: BSX) by 15.5% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. T
Baader Bank Aktiengesellschaft decreased its holdings in Boston Scientific Corporation (NYSE: BSX) by 50.5% in the undefined quarter, according to the company in its most recent Form 13F filing with t
Andra AP fonden lifted its holdings in Boston Scientific Corporation (NYSE: BSX) by 144.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exch
Bessemer Group Inc. reduced its holdings in shares of Boston Scientific Corporation (NYSE: BSX) by 98.8% during the first quarter, according to its most recent 13F filing with the Securities and Excha
Boston Scientific (BSX) reached $43.19 at the closing of the latest trading day, reflecting a -1.33% change compared to its last close.

Artisan Value Fund Q2 2026 Portfolio Update

11:25am, Tuesday, 21'st Jul 2026
US equities advanced during Q2, supported by another quarter of better-than-expected corporate earnings and continued enthusiasm for companies benefiting from artificial intelligence-related investmen
BSX faces Q2 results with growth expected in key businesses, but lowered full-year guidance, cost pressures and weak stock performance cloud the outlook.
Allspring Global Investments Holdings LLC reduced its holdings in shares of Boston Scientific Corporation (NYSE: BSX) by 49.7% in the first quarter, according to its most recent filing with the SEC. T
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE